Dare Bioscience (DARE) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Dare Bioscience (DARE) over the last 4 years, with Q3 2025 value amounting to 26.97%.
- Dare Bioscience's Return on Capital Employed fell 239500.0% to 26.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 26.97%, marking a year-over-year decrease of 239500.0%. This contributed to the annual value of 298.34% for FY2024, which is 2957800.0% down from last year.
- Dare Bioscience's Return on Capital Employed amounted to 26.97% in Q3 2025, which was down 239500.0% from 5.4% recorded in Q2 2025.
- Over the past 5 years, Dare Bioscience's Return on Capital Employed peaked at 49.49% during Q1 2024, and registered a low of 26.97% during Q3 2025.
- Moreover, its 4-year median value for Return on Capital Employed was 1.57% (2022), whereas its average is 2.93%.
- As far as peak fluctuations go, Dare Bioscience's Return on Capital Employed surged by 519500bps in 2024, and later crashed by -239500bps in 2025.
- Dare Bioscience's Return on Capital Employed (Quarter) stood at 2.1% in 2022, then crashed by -448bps to 11.51% in 2023, then surged by 233bps to 15.3% in 2024, then crashed by -276bps to 26.97% in 2025.
- Its Return on Capital Employed was 26.97% in Q3 2025, compared to 5.4% in Q2 2025 and 26.58% in Q1 2025.